16:11 EDT Oric Pharmaceuticals (ORIC) files to sell 19.23M shares of common stock for holders
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ORIC:
- Promising Potential of ORIC-944 in mCRPC Treatment Drives Buy Rating and $22 Price Target
- Court blocks Trump tariffs, Musk steps away from DOGE: Morning Buzz
- Oric Pharmaceuticals data ‘home run scenario,’ says JPMorgan
- Buy Rating for Oric Pharmaceuticals Driven by Promising ORIC-944 Study Results and Undervaluation
- Closing Bell Movers: Nvidia gains 4% on earnings, lifting other semis